相关实验视频

Updated: Sep 13, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

在创伤性脑损伤后的DPP-4抑制剂患者中,优糖性DKA:一个复杂的ICU葡萄糖管理挑战

Isam Shammas¹, Mohammed Seyaj¹, Kenana Altell²

¹Department of Surgical ICU, Al-Ahli Hospital, Hebron, State of Palestine.

|July 29, 2025

概括

优糖性糖尿病酸性酸症 (EuDKA) 是一种罕见的疾病,模仿DKA而没有高血糖. 这一案例凸显了Eudka在服用DPP-4抑制剂的患者中存在的风险,特别是在创伤后.

科学领域:

内分泌学在内分泌学.
药理学药理学是指药理学的学科.

背景情况:

优糖性糖尿病酸症 (EuDKA) 是一种罕见的糖尿病酸症 (DKA) 变体,呈现出正常的葡萄糖水平,造成诊断挑战.
最近的研究表明,Eudka与二二酶-4 (DPP-4) 抑制剂之间存在联系,这是一类抗糖尿病药物.

研究的目的:

在创伤性脑损伤后报告患有2型糖尿病患者的EuDKA病例.
突出DPP-4抑制剂在EuDKA沉中的潜在作用,特别是在代谢压力下.

主要方法:

一名57岁的男性患有2型糖尿病和其他并发症,在创伤性脑损伤后患上了EuDKA.
临床表现包括严重的代谢酸症,症和正常的血糖 (134 mg/dL).
该患者正在服用西塔格利平丁,一种DPP-4抑制剂.

主要成果:

患者呈现出严重的酸化 (pH 7.16),低碳酸盐 (2.8 mmol/L),升高的离子间隙 (24.9 mmol/L) 和阳性尿.
尽管血糖正常,但EuDKA的诊断得到了证实.
患者在液体复苏,胰岛素治疗和电解质校正后完全康复.

结论:

这一案例凸显了在创伤患者中怀疑EuDKA的重要性,特别是那些使用DPP-4抑制剂的人.
迅速的认可和干预对于EuDKA的良好结果至关重要.
需要进一步的研究来阐明在代谢应激条件下连接DPP-4抑制剂和EuDKA的机制.

关键词:

DPP-4 抑制剂的使用在ICU中,医生会对患者进行治疗.这是一个TBI,TBI.优糖血症糖尿病酸性脂肪酸症

更多相关视频

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...

SBAR II: Application of SBAR

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...